| Title | Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. |
| Publication Type | Journal Article |
| Year of Publication | 2015 |
| Authors | Frigault MJ, Lee J, Basil MCiocca, Carpenito C, Motohashi S, Scholler J, Kawalekar OU, Guedan S, McGettigan SE, Posey AD, Ang S, Cooper LJN, Platt JM, F Johnson B, Paulos CM, Zhao Y, Kalos M, Milone MC, June CH |
| Journal | Cancer Immunol Res |
| Volume | 3 |
| Issue | 4 |
| Pagination | 356-67 |
| Date Published | 2015 Apr |
| ISSN | 2326-6074 |
| Keywords | Animals, CD28 Antigens, CD3 Complex, Cell Proliferation, Chemokines, Cytokine-Induced Killer Cells, Cytokines, Female, Genetic Vectors, Humans, Immunophenotyping, Immunotherapy, Adoptive, Interleukin-2, Lentivirus, Lymphocyte Activation, Mice, Inbred NOD, Mice, SCID, Ovarian Neoplasms, Receptors, Antigen, T-Cell, Recombinant Fusion Proteins, Signal Transduction, T-Lymphocytes, Xenograft Model Antitumor Assays |
| Abstract | This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-κB, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials. |
| DOI | 10.1158/2326-6066.CIR-14-0186 |
| Alternate Journal | Cancer Immunol Res |
| PubMed ID | 25600436 |
| PubMed Central ID | PMC4390458 |
| Grant List | P01 CA066726 / CA / NCI NIH HHS / United States 2P30CA016520 / CA / NCI NIH HHS / United States R01 CA105216 / CA / NCI NIH HHS / United States R01 CA175061 / CA / NCI NIH HHS / United States P01CA066726 / CA / NCI NIH HHS / United States R01CA105216 / CA / NCI NIH HHS / United States P30 CA016520 / CA / NCI NIH HHS / United States P01 CA148600 / CA / NCI NIH HHS / United States R01 CA165206 / CA / NCI NIH HHS / United States 2PN2EY016586 / EY / NEI NIH HHS / United States R01CA120409 / CA / NCI NIH HHS / United States PN2 EY016586 / EY / NEI NIH HHS / United States T32 HL007586 / HL / NHLBI NIH HHS / United States 3T32GM007170-36S1 / GM / NIGMS NIH HHS / United States T32 GM007170 / GM / NIGMS NIH HHS / United States R01 CA120409 / CA / NCI NIH HHS / United States |
